ncs

Documents about ncs

• 0004 — NCS TECHNOLOGIES INC — Social Security Administration ($90,688,489)#601405USAspending
• 28321320FA0010119 — NCS TECHNOLOGIES INC — Social Security Administration ($59,536,345)#601569USAspending
• 0013 — NCS TECHNOLOGIES INC — Social Security Administration ($48,385,501)#601694USAspending
• 28321326FA0010118 — NCS TECHNOLOGIES INC — Social Security Administration ($37,231,390)#601924USAspending
• 28321320FA0010381 — NCS TECHNOLOGIES INC — Social Security Administration ($36,383,012)#601947USAspending
• 28321318FA0010463 — NCS TECHNOLOGIES INC — Social Security Administration ($35,292,623)#601970USAspending
• 2032H524F00443 — NCS TECHNOLOGIES INC — Department of the Treasury ($27,788,127)#602263USAspending
• 2032H524F00250 — NCS TECHNOLOGIES INC — Department of the Treasury ($21,322,000)#602673USAspending
• HSSCCG05F0539 — NCS PEARSON, INC. — Department of Homeland Security ($29,687,943)#602159USAspending
• Reliability and Validity of the NCS (NCS-R)-Chinese Version#1231576ClinicalTrials.gov
• Non-collinear magnetism in the post-perovskite thiocyanate frameworks CsM(NCS)_\textrm3#176804HAL (France)
• Magnetic structure and properties of the honeycomb antiferromagnet [Na(OH2)3]Mn(NCS)3#7677HAL (France)
• The NCS-Model: A seismic foundation model trained on the Norwegian repository of public data#1144775arXiv (All)
• A Study of NCS-01 in Patients With Acute Ischemic Stroke#1163595ClinicalTrials.gov
• The neurobiological cravings signature (NCS) as a predictive neuromarker of clinical outcomes in alcohol use disorder#253603Europe PMC
• Stability of multiplexed NCS based on an epsilon-greedy algorithm for communication selection ⋆#226805HAL (France)
• Synthesis route and structural, magnetic, optical, and non-linear optical properties of triboluminescent [Cu(NCS)(py)2(PPh3)] complex#354054HAL (France)
• Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas#1398120ClinicalTrials.gov
• Nursing Competency Scale for Patients With Comorbid Cancer and Dementia in Acute Care Hospitals (NCS-CD): Development and Validation.#1107387NCBI PubMed Central
• Biogenic E. coli EPS-capped Ag/ZrO(2) nanocomposites (Ag/ZrO(2) NCs): synthesis, characterization, and multitarget biomedical activity.#785748NCBI PubMed Central
• Behavioral Assessment of Nociception on NCS-R#979040ClinicalTrials.gov
• Effectiveness of Supervised Training Program on Mobility and Balance Confidence in Individual With Lower Limb Amputation#1293711ClinicalTrials.gov
• Association Between Microvascular Retinal Signs and Age-Related Hearing Loss in the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)#384050CiNii
• A resource-efficient structure-based workflow for fragment progression enables parallel hit discovery and validation of functionally diverse modulators of NCS-1 protein-protein interactions.#975715NCBI PubMed Central
• Relating teachers' content knowledge to learner performance in probability#649274University of Pretoria Repository
• Key Properties to Utilize in Plasmonic Metal Oxide Nanocrystals for Catalytic Conversion of Molecules#208543Figshare
• Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance#1349755ClinicalTrials.gov
• Síntesis y caracterización de soluciones coloidales con nanopartículas de silicio y su uso en estructuras Al/SC-Si-ncs/SiP/Si/Al#647124Repositorio Institucional BUAP
• Ireland – Medical equipments – Contract with Options for the Supply, Support and Maintenance of EMG/NCS Systems — Beaumont Hospital_403 (IRL) · 2000000 EUR#1392215EU TED (Tenders Electronic Daily)
• Bioinspired Ag/CeO<sub>2</sub> and Ag/Bi<sub>2</sub>O<sub>3</sub> nanohybrids synthesized with Nauplius graveolens for antioxidant, antibacterial, and insecticidal applications#123304Europe PMC
• Spectral diffusion in the <sup>2</sup> E ←  <sup>4</sup> A <sub>2</sub> spin-flip transition of [Cr(NCS) <sub>6</sub> ] <sup>3−</sup> in glycerol#400752Open Research